| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 1422506-53-3 | Rauvotetraphylline E | C20H18N2O3 |
| 1422514-05-3 | Rosuvastatin EP Impurity C (Calcium Salt) | C44H50CaF2N6O12S2 |
| 1422515-52-3 | Fexofenadine N-Oxide | C32H39NO5 |
| 1422515-55-6 | Calcium (3R,5R,6E)-7-[4-(4-fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]-3,5-dihydroxy-6-heptenoate (1:2) | Ca(C22H27FN3O6S)2 |
| 1422619-13-3 | (3R,6E)-7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]-3-hydroxy-5-oxo-6-heptenoic acid | C22H26FN3O6S |
| 1422731-37-0 | APTO-253 (LOR253 HCl) | |
| 1422954-11-7 | Rosuvastatin (3R,5R)-Lactone | C22H26FN3O5S |
| 1422954-12-8 | 2,3-Anhydro rosuvastatin calcium | C22H25FN3O5S.1/2Ca |
| 1422956-31-7 | 5-(1-Piperazinyl)-2-benzofurancarboxylic acid ethyl ester dihydrochloride hydrate | C15H18N2O3.2(HCl).H2O |
| 1423018-01-2 | Ethyl thio-beta-D-galactopyranoside 2,4,6-tribenzoate | C29H28O8S |
| 1423030-14-1 | (Z)-3-(3-Bromo-4-fluorobenzylidene)isobenzofuran-1(3H)-one | C15H8BrFO2 |
| 1423030-97-0 | 2',3'-Dihydrospiro[cyclopropane-1,1'-inden]-2-amine Hydrochloride | C11H14ClN |
| 1423119-98-5 | Dabrafenib-d9 | C23H11D9F3N5O2S2 |
| 1423318-02-8 | 2,2-Didecyl-1,3-propanediyl bis-beta-D-glucopyranoside | C35H68O12 |
| 1423715-09-6 | 3-(4-Morpholinylsulfonyl)benzoic acid (2E)-2-[1-(5-chloro-2-hydroxyphenyl)ethylidene]hydrazide | C19H20ClN3O5S |
| 1423738-74-2 | 1-Bromo-4-[2-(4-ethylphenyl)ethyl]benzene | C16H17Br |
| 1423739-88-1 | 1-Bromo-4-[2-(4-pentylphenyl)ethyl]benzene | C19H23Br |
| 1423809-64-6 | 3,8-Dioxo-7alpha-hydroxy-4,11(12)-tetradehydrocadinanene | C15H20O3 |
| 1424059-28-8 | 8-Fluoro-1,3,4,5-tetrahydro-2-[4-[(E)-(methylimino)methyl]phenyl]-6H-pyrrolo[4,3,2-ef][2]benzazepin-6-one | C19H16FN3O |
| 1424245-91-9 | 7-Chloro-3-iodoquinoline | C9H5ClIN |
| 1424245-96-4 | 3-Iodo-8-methylquinoline | C10H8IN |
| 1424857-63-5 | 7-[4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butoxy]-3,4-dihydro-1-[4-[(1,2,3,4-tetrahydro-2-oxo-7-quinolinyl)oxy]butyl]-2(1H)-quinolinone | C36H42Cl2N4O4 |
| 1424858-02-5 | Aripiprazole Impurity 47 | C26H32N2O5 |
| 1425038-19-2 | 3-Methyl-N-[[[(1R,2R)-2-(4-pentyn-1-yl)cyclopropyl]oxy]carbonyl]-L-valine | C15H23NO4 |
| 1425038-20-5 | (4R)-4-[(3-Chloro-7-methoxy-2-quinoxalinyl)oxy]-L-proline methyl ester methanesulfonate | C15H16ClN3O4.CH4O3S |
| 1425038-21-6 | (S)-3,3-Dimethyl-2-((((1R,2R)-2-(pent-4-yn-1-yl)cyclopropoxy)carbonyl)amino)butyric acid tert-butylamine salt | C15H23NO4.C4H11N |
| 1425038-23-8 | (1aR,5S,8S,10R,22aR)-18,19-Didehydro-5-(1,1-dimethylethyl)-1,1a,3,4,5,6,9,10,20,21,22,22a-dodecahydro-14-methoxy-3,6-dioxo-8H-7,10-methanocyclopropa[18,19][1,10,3,6]dioxadiazacyclononadecino[11,12-b]quinoxaline-8-carboxylic acid methyl ester | C30H36N4O7 |
| 1425038-27-2 | MK-5172 sodium salt | C38H49N6NaO9S |
| 1425254-01-8 | (1S,3R)-(3-Hydroxy-cyclohexyl)-carbamic acid tert-butyl ester | C11H21NO3 |
| 1425485-72-8 | DBCO-C6-acid | C21H19NO3 |
| 1425927-75-8 | 6-Amino-1,3-dimethyl-1H-quinolin-2-one | C11H12N2O |
| 1425931-95-8 | 5-(3,3-Difluorocyclobutyl)-1H-pyrazol-3-amine | C7H9F2N3 |
| 1425938-63-1 | (4S)-3-[(2S,3R)-3-(1,1-Dimethylethoxy)-2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-1-oxobutyl]-2,2-dimethyl-4-oxazolidinecarboxylic acid | C29H36N2O7 |
| 1425938-66-4 | N-[(2,4-Dimethoxyphenyl)methyl]-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-alanine | C27H27NO6 |
| 1426129-50-1 | N-[(1R)-2-[1,1'-Biphenyl]-4-yl-1-(hydroxymethyl)ethyl]carbamic acid 1,1-dimethylethyl ester | C20H25NO3 |
| 1426132-38-8 | 3-[[(Methylthio)methoxy]methoxy]propanenitrile | C6H11NO2S |
| 1426135-66-1 | 5,5-Difluorooxane-2-carboxylic acid | C6H8F2O3 |
| 1426138-42-2 | (5Z)-5-(5-Chloro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)-4-oxo-2-thioxo-3-thiazolidinepropanoic acid | C14H9ClN2O4S2 |
| 1426155-88-5 | 2-Amino-5-methoxybenzenephosphonic acid | C7H10NO4P |
| 1426160-58-8 | ASGPR ligand-1 | C61H110N10O27 |
| 1426173-86-5 | Silodosin-d4 | C25D4H28F3N3O4 |
| 1426174-31-3 | (9R,12R,15R,18R,21R)-21-Amino-2-((2R,5R,8R,11R,14R)-2-amino-14-(4-aminobutyl)-5-benzyl-11-isobutyl-8-isopropyl-3,6,9,12,15-pentaoxo-1-phenyl-4,7,10,13,16-pentaazaicosan-20-yl)-9-(4-aminobutyl)-18-benzyl-12-isobutyl-15-isopropyl-4,8,11,14,17,20-hexaoxo-22-phenyl-3,7,10,13,16,19-hexaazadocosan-1-oic acid | C79H119N15O13 |
| 1426174-36-8 | (2S)-N’-Nitrosonornicotine-d4 | C9H7D4N3O |
| 1426174-41-5 | Ezetimibe phenoxy glucuronide-D4 | C30H25D4F2NO9 |
| 1426174-82-4 | (S)-N-Nitroso Anatabine-d4 | C10H7D4N3O |
| 1426290-08-5 | 5-Bromo-2-chloro-4-fluorophenylacetonitrile | C8H4BrClFN |
| 1426435-71-3 | 4-(1-benzothiophen-2-yl)-N-[4-(1-benzothiophen-2-yl)phenyl]aniline | C28H19NS2 |
| 1426530-29-1 | benzyl 2,4-bis(benzyloxy)-6-chloro-5-ethylnicotinate | |
| 1426566-90-6 | 4-Bromo-3-chloro-2-iodobenzenamine | C6H4BrClIN |
| 1426572-43-1 | Sodium [(2S,5R)-2-(5-methyl-1,3,4-oxadiazol-2-yl)-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl] sulfate | C9H11N4NaO6S |